NeuroPace

NPCE62

$9.72arrow_drop_up5.72%$0.51

NPCE62

$9.72

arrow_drop_up5.72%$0.51

Performance History

Key Stats
Open	$9.24
Prev. Close	$9.18
EPS	-0.98
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	8.92	9.27
52 Week Range	5.75	18.15

Ratios







EPS	-0.98

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About NeuroPace (NPCE)

NeuroPace, Inc. (NPCE) is a medical technology company that specializes in developing and commercializing innovative therapies for patients with neurological disorders. The company is best known for its flagship product, the RNS® System, which is an implantable device that provides personalized neurostimulation therapy for patients with refractory epilepsy. The RNS System is designed to continuously monitor brain activity, identify and respond to abnormal electrical signals that can lead to seizures. By providing targeted neuromodulation, the RNS System aims to reduce the frequency and severity of seizures in patients who have not responded well to traditional treatment options.

As of the latest available stock price history, NeuroPace, Inc. (NPCE) has shown a steady upward trend. The stock has experienced consistent growth over the past year, with a significant increase in value. Investors have been optimistic about the company's prospects, as it continues to make advancements in the field of neurostimulation therapy. The market cap of NeuroPace, Inc. currently stands at [insert market cap value here], reflecting the strong investor interest in the company's innovative products.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Joel D. Becker
Headquarters: Mountain View
Employees: 169
Exchange: NASDAQ

Keep an eye on NeuroPace

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is NeuroPace's (NPCE) price per share?

The current price per share for NeuroPace (NPCE) is $9.72. The stock has seen a price change of $0.52 recently, indicating a 5.72% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for NeuroPace (NPCE)?

For NeuroPace (NPCE), the 52-week high is $18.15, which is 86.63% from the current price. The 52-week low is $5.75, the current price is 69.13% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is NeuroPace (NPCE) a growth stock?

NeuroPace (NPCE) has shown an average price growth of -6.03% over the past three years. It has received a score of 94 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying NeuroPace as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is NeuroPace (NPCE) stock price performance year to date (YTD)?

As of the latest data, NeuroPace (NPCE) has a year-to-date price change of -0.56%. Over the past month, the stock has experienced a price change of 56.85%. Over the last three months, the change has been 30.89%. Over the past six months, the figure is 22.33%.

help

Is NeuroPace (NPCE) a profitable company?

NeuroPace (NPCE) has a net income of -$32.96M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 73.56% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -20.15% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $65.42M, with a revenue growth rate of 43.72%, providing insight into the company's sales performance and growth. The gross profit is $48.12M. Operating income is noted at -$27.17M. Furthermore, the EBITDA is -$22.87M.

help

What is the market capitalization of NeuroPace (NPCE)?

NeuroPace (NPCE) has a market capitalization of $282.06M. The average daily trading volume is 9.33, indicating the stock's liquidity and investor engagement.